AXT Inc. (NASDAQ: AXTI) reported that Chief Financial Officer Gary L. Fischer sold 8,256 shares of common stock on March 12, 2026, and 80,776 shares on March 13, 2026, according to a Form 4 filed with the Securities and Exchange Commission. Combined proceeds from the two-day program were about $4.5 million.
The March 12 transaction carried a weighted average sale price of $50.1975 per share, with individual trades ranging from $50.02 to $50.72. The following day saw a weighted average sale price of $50.6427, and individual execution prices on March 13 spanned $50.19 to $51.38. These sales occurred while the shares were trading near a 52-week high of $51.98, after a remarkable 2,614% return over the prior 12 months.
After the reported dispositions, Fischer retains direct ownership of 191,278 shares of AXT common stock.
Company guidance and analyst responses
In other company disclosures, AXT revised its fourth-quarter revenue projection downward to a range of $22.5 million to $23.5 million, compared with an earlier expectation of $27 million to $30 million. The company attributed the reduced outlook to fewer export permits for indium phosphide substrates being issued by China’s Ministry of Commerce, which has constrained its ability to fulfill customer orders.
The guidance change has been met with differing responses from sell-side analysts. Craig-Hallum increased its price target on AXT from $10 to $26 and maintained a Buy rating, citing robust demand and the potential for competitive constraints to support the company. Conversely, B. Riley adjusted its rating from Buy to Neutral, pointing to valuation concerns even as it raised its price target to $18.
Wider industry developments noted by analysts
Needham made broader moves across semiconductor equipment names. The firm upgraded Nova Measuring Instruments to Buy from Hold and set a price target of $500, noting strong global execution and positioning to benefit from China’s memory wafer fabrication equipment market in 2026. Needham also upgraded Ichor Holdings to Buy with a $36 price target, describing it as a potential derivative play alongside larger semiconductor equipment manufacturers.
These analyst actions and the company’s revised revenue outlook highlight shifts in supply-chain constraints and competitive dynamics within the semiconductor equipment and materials sectors.
Valuation note and available analysis
InvestingPro analysis, as cited in company-related commentary, indicates that AXT’s shares appear overvalued at current levels. The platform offers a Fair Value analysis and additional proprietary tips for investors evaluating AXTI, according to the disclosure in the filing.
Investors should weigh the insider sales and guidance revision alongside analyst views and industry positioning when assessing near-term risk and longer-term opportunity in AXT and related equipment names.